Collectively, our findings demonstrated that ELK1 functioned as a facilitator of chemoresistance in osteosarcoma cells by increasing cell viability and proliferation via miR-134 inhibition and upregulation of PTBP1. The gene discussed is PTBP1; the disease is osteosarcoma.